Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche and Affymetrix expand license agreement
The expanded license now provides certain diagnostic rights for array-based DNA copy number analysis and array-based re-sequencing in addition to covering the manufacture, use and sale of nucleic
The expanded license now provides certain diagnostic rights for array-based DNA copy number analysis and array-based re-sequencing in addition to covering the manufacture, use and sale of nucleic
This represents Synbiotics first foray into the human point-of-care diagnostic marketplace. While it is not Synbiotics’s initial intent to market this product itself to the human field, it
Salix is required to make an up-front payment and regulatory milestone payments to Dr Falk Pharma, with the majority contingent upon achievement of US regulatory approval. In addition,
The approval of the fifth consecutive dose of Daptacel vaccine completes the FDA license for the entire five-dose Daptacel vaccine series enabling health-care professionals to administer the same
Medegen continues to believe that ICU’s valve product, CLC-2000, infringes on the company’s patent for its proprietary valve technology. This patent covers a number of Medegen’s novel inventions
Option inferior vena cava (IVC) filter is a medical device that is implanted into the body’s inferior vena cava to prevent pulmonary embolism. Rex Medical anticipates that the
Sagent will begin marketing and shipping Cefazolin immediately. Cefazolin for injection, USP, is the generic equivalent of GlaxoSmithKline’s Ancef, an antibiotic used to treat bacterial infections. Cefazolin for
For the planned series of Phase II multi-centered, controlled clinical trials to be performed in the US, Innocoll has appointed Premier Research Group to co-ordinate up to five
The first product to be developed will target the hepatitis B hyperimmune. Kedrion has in-licensed ProMetic’s technologies for the manufacturing of hyperimmune products in Europe. Royalties, licensing and
Glenmark commenced shipping immediately upon final approval from the FDA for an abbreviated new drug application (ANDA) for Nabumetone tablets in 500mg and 750mg strengths and Hydroxyzine hydrochloride